BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19764478)

  • 21. Endothelial control of the cardiovascular system: recent advances.
    Griendling KK; Alexander RW
    FASEB J; 1996 Feb; 10(2):283-92. PubMed ID: 8641561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of thrombin receptors in the kidney: lessons from PAR1 knock-out mice.
    Rondeau E; Vigneau C; Berrou J
    Nephrol Dial Transplant; 2001 Aug; 16(8):1529-31. PubMed ID: 11477146
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversible cerebral vasoconstriction syndrome.
    Ducros A; Bousser MG
    Pract Neurol; 2009 Oct; 9(5):256-67. PubMed ID: 19762885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EDHF story: the plot thickens.
    Parkington HC; Tare M; Coleman HA
    Circ Res; 2008 May; 102(10):1148-50. PubMed ID: 18497313
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of gamma-thrombin-induced human platelet aggregation by histone H1subtypes and H1.3 fragments.
    Soslau G; Prest PJ; Class R; Jost M; Mathews L
    Platelets; 2009 Aug; 20(5):349-56. PubMed ID: 19637099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapeutic targets in vascular biology.
    Imhof BA; Vadas MA
    Thromb Haemost; 2003 Oct; 90(4):557-9. PubMed ID: 14515170
    [No Abstract]   [Full Text] [Related]  

  • 27. [Application of the FloTrac arterial pressure-based continuous cardiac output monitor to dobutamine-induced hyperdynamic therapy for cerebral vasospasm after subarachnoid hemorrhage].
    Mutoh T; Ishikawa T; Yasui N
    No Shinkei Geka; 2009 Nov; 37(11):1085-93. PubMed ID: 19938664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter in response to 'Coagulation and fibrosis in chronic liver disease'.
    Borensztajn K; Peppelenbosch MP; Spek CA
    Gut; 2009 Nov; 58(11):1565-6. PubMed ID: 19834120
    [No Abstract]   [Full Text] [Related]  

  • 29. Cadmium attenuates bradykinin-driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase.
    Majumder S; Gupta R; Reddy H; Sinha S; Muley A; Kolluru GK; Chatterjee S
    Biochem Cell Biol; 2009 Aug; 87(4):605-20. PubMed ID: 19767824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherothrombotic disorders: new insights from hematology.
    Andreotti F; Becker RC
    Circulation; 2005 Apr; 111(14):1855-63. PubMed ID: 15824214
    [No Abstract]   [Full Text] [Related]  

  • 31. Free radicals and vascular disease: how much do we know?
    Halliwell B
    BMJ; 1993 Oct; 307(6909):885-6. PubMed ID: 8241848
    [No Abstract]   [Full Text] [Related]  

  • 32. Etomidate, nitric oxide, and cerebral vasospasm.
    Mashour GA
    Anesth Analg; 2008 Jul; 107(1):343; author reply 343-4. PubMed ID: 18635509
    [No Abstract]   [Full Text] [Related]  

  • 33. Pre-diabetes may cause blood vessel damage.
    Health News; 2004 Sep; 10(9):9. PubMed ID: 15597447
    [No Abstract]   [Full Text] [Related]  

  • 34. Par-4 keeps the atypical PKCs at bay.
    Moscat J; Diaz-Meco MT
    Cell Cycle; 2003; 2(2):71-2. PubMed ID: 12695647
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
    John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
    Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saturated fat and vascular compliance.
    Feinman R
    J Am Diet Assoc; 2009 Sep; 109(9):1524-5; author reply 1525, 1527. PubMed ID: 19699829
    [No Abstract]   [Full Text] [Related]  

  • 37. Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo.
    Perez M; Lamothe M; Maraval C; Mirabel E; Loubat C; Planty B; Horn C; Michaux J; Marrot S; Letienne R; Pignier C; Bocquet A; Nadal-Wollbold F; Cussac D; de Vries L; Le Grand B
    J Med Chem; 2009 Oct; 52(19):5826-36. PubMed ID: 19791800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression.
    Parrales A; Palma-Nicolás JP; López E; López-Colomé AM
    J Cell Physiol; 2010 Feb; 222(2):302-12. PubMed ID: 19847806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human-derived clotting agent avoids immunogenicity.
    Morrow T
    Manag Care; 2007 Dec; 16(12):50-1. PubMed ID: 18198731
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on "Reversible cerebral vasoconstriction syndrome".
    Dash SK
    J Clin Neurosci; 2009 Oct; 16(10):1376; author reply 1377. PubMed ID: 19574049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.